Leukemia Clinical Trials in Nashville

Showing 1121-1140 of 1,521 trials

Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery

NCT01207726

This study combines the deoxyribonucleic acid (DNA) methyltransferase inhibitor, 5-azacitidine (5-AZA), with an orally bioavailable histone deacetylase inhibitor, entinostat (SNDX-275), for the adjuvant treatment of patients with resected stage I non-small cell lung cancer (NCSLC).

Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma

National Cancer Institute (NCI)13 participantsStarted Sep 2010

Los Angeles, California, United States • Tampa, Florida, United States • Annapolis, Maryland, United States +6 more locations

TERMINATEDPhase 2< 1 mile

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

NCT01497665

The purpose of this study is to assess the efficacy, safety, and tolerability of GRN1005 in patients with brain metastases from non-small cell lung cancer (NSCLC).

Non-small Cell Lung Cancer (NSCLC) With Brain Metastases

Angiochem Inc16 participantsStarted Nov 2011

La Jolla, California, United States • Aurora, Colorado, United States • Tampa, Florida, United States +7 more locations

Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Leukemia Trials in Other Cities

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Early Diagnosis of Candidiasis in Premature Infants

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations

Other Conditions in Nashville